Page last updated: 2024-09-04
ci 922 and phenidone
ci 922 has been researched along with phenidone in 1 studies
Compound Research Comparison
| Studies (ci 922) | Trials (ci 922) | Recent Studies (post-2010) (ci 922) | Studies (phenidone) | Trials (phenidone) | Recent Studies (post-2010) (phenidone) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 184 | 0 | 11 |
Protein Interaction Comparison
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Conroy, MC; Kennedy, JA; Thueson, DO | 1 |
Other Studies
1 other study(ies) available for ci 922 and phenidone
| Article | Year |
|---|---|
Differential inhibition of histamine release from human basophils induced by antigen, anti-IgE or N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Antibodies, Anti-Idiotypic; Antigens; Basophils; Catechols; Cells, Cultured; Chromones; Histamine Release; Humans; Immunoglobulin E; Indoles; Indomethacin; Masoprocol; Meclofenamic Acid; N-Formylmethionine Leucyl-Phenylalanine; Oxazoles; Pyrazoles; Receptors, Fc; Receptors, Formyl Peptide; Receptors, IgE; Receptors, Immunologic; Tetrazoles | 1985 |